CX3CL1 and tarsal-carpal coalition syndrome: To evaluate whether CX3CL1 expression is associated with disease aggressiveness with functional experiments, we evaluated the expression levels in 3 different types of cell lines, TCCSUP (grade IV cancer), 5637 (grade II cancer), and T24 cells (high-grade and invasive TCC).